This article has been cited by
1Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
Tai-Lung Cha,Tony Tong-Lin Wu,Nicholas John Vogelzang,Chao-Yuan Huang,Shu-Pin Huang,Chia-Chi Lin,Yen-Chuan Ou,See-Tong Pang,Daniel Heung-Yuan Shen,Wen-Jeng Wu,Wayne Yen-Hwa Chang
Journal of the Formosan Medical Association.2017;116(11)825
[DOI]
2The role of taxanes in prostate cancer: literature review
A. K. Norsov,S. A. Reva
Cancer Urology.2018;14(2)130
[DOI]
3Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Deepali Waghray,Qinghai Zhang
Journal of Medicinal Chemistry.2018;61(12)5108
[DOI]
4Fluorescent dyes and probes for super-resolution microscopy of microtubules and tracheoles in living cells and tissues
Gražvydas Lukinavicius,Gyuzel Y. Mitronova,Sebastian Schnorrenberg,Alexey N. Butkevich,Hannah Barthel,Vladimir N. Belov,Stefan W. Hell
Chemical Science.2018;9(13)3324
[DOI]
5Navigating the evolving therapeutic landscape in advanced prostate cancer
E. David Crawford,Daniel Petrylak,Oliver Sartor
Urologic Oncology: Seminars and Original Investigations.2017;35(13)S1
[DOI]
6Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations
Nicholas Ekow Thomford,Kevin Dzobo,Emile Chimusa,Kerstin Andrae-Marobela,Shadreck Chirikure,Ambroise Wonkam,Collet Dandara
OMICS: A Journal of Integrative Biology.2018;22(6)375
[DOI]
7Regulation of local steroidogenesis in the brain and in prostate cancer: Lessons learned from interdisciplinary collaboration
H. Bobby Fokidis,Hans H. Adomat,Geetanjali Kharmate,Elham Hosseini-Beheshti,Emma S. Guns,Kiran K. Soma
Frontiers in Neuroendocrinology.2015;36(6)108
[DOI]
8Formulation of Acid-Sensitive Micelles for Delivery of Cabazitaxel into Prostate Cancer Cells
Omer Aydin,Ibrahim Youssef,Yasemin Yuksel Durmaz,Gopinath Tiruchinapally,Mohamed E. H. ElSayed
Molecular Pharmaceutics.2016;13(4)1413
[DOI]
9Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
Pallavi Duggal,Sidharth Mehan
Journal of Alzheimer's Disease Reports.2019;3(1)179
[DOI]
10UV spectroscopy and least square matching for high throughput discrimination of taxanes in commercial formulations and compounded bags
E. Jaccoulet,C. Boughanem,L. Auduteau,P. Prognon,E. Caudron
European Journal of Pharmaceutical Sciences.2018;123(1)143
[DOI]
11Mass spectrometry in the pharmacokinetic studies of anticancer natural products
Sara Crotti,Bianca Posocco,Elena Marangon,Donato Nitti,Giuseppe Toffoli,Marco Agostini
Mass Spectrometry Reviews.2017;36(2)213
[DOI]
12Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer
Bryan Hoang,Mark J. Ernsting,Wei-Hsin Sophia Tang,Joseph Bteich,Elijus Undzys,Taira Kiyota,Shyh-Dar Li
Cancer Letters.2017;410(2)169
[DOI]
13Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer
Shaheen Mahira,Nagavendra Kommineni,Gulam Mohammed Husain,Wahid Khan
Biomedicine & Pharmacotherapy.2019;110(2)803
[DOI]
14SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma
Ignacio Duran,Carlos Hagen,José Ángel Arranz,María Apellaniz-Ruiz,Begoña Pérez-Valderrama,Nuria Sala,Nuria Lainez,Xavier García-Del Muro,Esther Noguerón,Miguel Ángel Climent,Pablo Maroto,Albert Font,Jesús García-Donas,Enrique Gallardo,Pilar López-Criado,Aránzazu González Del Alba,María Isabel Sáez,Sergio Vázquez,Raquel Luque,Cristina Rodríguez-Antona
Pharmacogenomics.2016;17(5)463
[DOI]
15Taxane anticancer agents: a patent perspective
Iwao Ojima,Brendan Lichtenthal,Siyeon Lee,Changwei Wang,Xin Wang
Expert Opinion on Therapeutic Patents.2016;26(1)1
[DOI]
16Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo
Guangyao Lv,Dengjun Sun,Jingwen Zhang,Xiaoxia Xie,Xiaoqiong Wu,Weishuo Fang,Jingwei Tian,Chunhong Yan,Hongbo Wang,Fenghua Fu
Acta Pharmaceutica Sinica B.2017;7(1)52
[DOI]
17Cell-Penetrating, Guanidinium-Rich Molecular Transporters for Overcoming Efflux-Mediated Multidrug Resistance
Jessica R. Vargas,Erika Geihe Stanzl,Nelson N. H. Teng,Paul A. Wender
Molecular Pharmaceutics.2014;11(8)2553
[DOI]
18Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells
Mirjam Gerwing,Christine Jacobsen,Sergey Dyshlovoy,Jessica Hauschild,Tina Rohlfing,Christoph Oing,Simone Venz,Jan Oldenburg,Karin Oechsle,Carsten Bokemeyer,Gunhild von Amsberg,Friedemann Honecker
Journal of Cancer Research and Clinical Oncology.2016;142(9)1979
[DOI]
19Self-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer
Bo Zhuang,Liang Du,Hongxia Xu,Xuelian Xu,Cheng Wang,Yingfang Fan,Mengyi Cong,Jiaqi Yin,Hongxia Li,Huashi Guan
International Journal of Pharmaceutics.2016;499(1-2)146
[DOI]
20Early investigational tubulin inhibitors as novel cancer therapeutics
Kunal Nepali,Ritu Ojha,Hsueh-Yun Lee,Jing-Ping Liou
Expert Opinion on Investigational Drugs.2016;25(8)917
[DOI]
21Redox-Sensitive Citronellol–Cabazitaxel Conjugate: Maintained in Vitro Cytotoxicity and Self-Assembled as Multifunctional Nanomedicine
Peng Xue,Dan Liu,Jing Wang,Na Zhang,Jiahua Zhou,Lin Li,Weiling Guo,Mengchi Sun,Xiangfei Han,Yongjun Wang
Bioconjugate Chemistry.2016;27(5)1360
[DOI]
  Feedback 
  Subscribe